Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Clinical Trial: Comparison of the Efficacy of Topical 0.2% Loteprednol Etabonate and Topical 0.1% Dexamethasone in Impending Recurrent Pterygium

NCT04075227 is registered in ClinicalTrials.gov with Wannisa Suphachearabhan as lead sponsor.

NCT NCT04075227
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04075227 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Clinical Trial: Comparison of the Efficacy of Topical 0.2% Loteprednol Etabonate and Topical 0.1% Dexamethasone in Impending Recurrent Pterygium
Lead sponsor
Wannisa Suphachearabhan
Phase
Phase 4
Overall status
Completed
Start date
October 16, 2015
Completion date
March 2, 2019
Enrollment
108 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent pterygium of eye, steroid-induced glaucoma